International Biotechnology Trust’s Legend Biotech LEGN Stock Holding History

International Biotechnology Trust’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$2.55M	Hold	38,000	–	–	0.86%	34
2023 Q2	$2.62M	Hold	38,000	–	–	0.8%	34
2023 Q1	$1.83M	Hold	38,000	–	–	0.51%	42
2022 Q4	$1.89M	Hold	38,000	–	–	0.59%	37
2022 Q3	$1.55M	Buy	38,000 +37,752	+15,223%	+$1.77M	0.5%	46
2022 Q2	$4.5K	Sell	248 -4,252	-94%	-$180K	0.05%	77
2022 Q1	$5.63M	Hold	4,500	–	–	1.27%	27
2021 Q4	$209K	Sell	4,500 -45,000	-91%	-$2.28M	0.05%	72
2021 Q3	$2.5M	Buy	+49,500	New	+$2.06M	0.6%	36

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

International Biotechnology Trust's LEGN Position: Q3 2023 in Review

International Biotechnology Trust held its Legend Biotech (LEGN) position steady in Q3 2023 at 38,000 shares worth $2.55M. The position accounts for 0.86% of the portfolio, ranked #34.

International Biotechnology Trust first reported a position in LEGN in Q3 2021 and has held it in 9 quarters since. The position peaked at $5.63M in Q1 2022. 200 funds tracked by Wall St. Rank hold LEGN as of Q3 2023.

International Biotechnology Trust held 38,000 shares of Legend Biotech worth $2.55M as of Q3 2023.
International Biotechnology Trust left its Legend Biotech share count unchanged in Q3 2023.
Legend Biotech made up 0.86% of International Biotechnology Trust's portfolio in Q3 2023, its #34 holding.
International Biotechnology Trust first reported a position in Legend Biotech in Q3 2021 and has held it in 9 quarters since.
International Biotechnology Trust's Legend Biotech position peaked at $5.63M in Q1 2022.
200 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.